Chemed
419 hedge funds and large institutions have $6.02B invested in Chemed in 2022 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 143 increasing their positions, 168 reducing their positions, and 41 closing their positions.
557% more call options, than puts
Call options by funds: $5.19M | Put options by funds: $791K
1.96% more ownership
Funds ownership: 90.15% → 92.11% (+2%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
10% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 41
2% less funds holding
Funds holding: 429 → 419 (-10)
5% less capital invested
Capital invested by funds: $6.34B → $6.02B (-$321M)
15% less repeat investments, than reductions
Existing positions increased: 143 | Existing positions reduced: 168
Top Buyers
Top Sellers
CHE Hedge Fund Activity: Q3 2022 in Review
419 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Chemed (CHE) for Q3 2022, worth a combined $6.02B — down 5.1% from $6.34B a quarter earlier.
Sellers outnumbered buyers: 41 funds closed out of CHE and 37 opened new positions — a net loss of 4 holders — while 168 trimmed existing stakes and 143 added.
The largest buyer was Vaughan Nelson Investment Management, opening a new position worth an estimated $83.3M. The largest seller was British Columbia Investment Management, cutting an estimated $34.1M.
- 419 institutional investors held Chemed (CHE) as of Q3 2022, down from 429 in Q2 2022.
- Funds reported $6.02B of Chemed stock for Q3 2022, down 5.1% quarter-over-quarter.
- 37 funds opened new Chemed positions in Q3 2022 and 41 closed out, a net change of -4 holders.
- The largest Chemed buyer in Q3 2022 was Vaughan Nelson Investment Management, an estimated $83.3M added.
- The largest Chemed seller in Q3 2022 was British Columbia Investment Management, an estimated $34.1M sold.
Based on aggregated 13F filings for Q3 2022.